Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyHighmark Delaware Pathology Update | OpenPayer
    Ask Trek AI about this page
    RetiredHighmark DelawarePolicy RP-074

    Diagnostic Pathology Services

    Customize your policy alerts

    Sign up for Highmark Delaware Policy RP-074 alerts

    Get alerted when Policy RP-074 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs reimbursement for covered diagnostic pathology services that lack pricing on the Medicare Clinical Laboratory Fee Schedule. It applies to providers submitting applicable professional claims in specified commercial and Medicare Advantage markets.

    Policy Summary
    PayerHighmark Delaware
    PolicyDiagnostic Pathology Services
    Policy CodePolicy RP-074
    Change TypeAdministrative retirement
    Effective DateAug 1, 2022
    Last ReviewSep 1, 2025
    Next Review DateN/A
    Key ActionApply 51% of billed charge when no Medicare Clinical Laboratory Fee Schedule fee is published.
    SourceLink
    POLICY UPDATE CHANGES

    The policy was end dated retroactively.

    70%Fee-schedule reimbursement
    51%Billed-charge reimbursement
    1500Applicable claim type

    Diagnostic Pathology Reimbursement Criteria

    Services without Medicare fee-schedule pricing

    For dates of service January 1, 2022, and thereafter, the Plan reimburses diagnostic pathology services without pricing on the Medicare Clinical Laboratory Fee Schedule as follows:

    ALL of the following

    • ALL of the following

      • Service is a diagnostic pathology service.
      • The service does not have pricing on the Medicare Clinical Laboratory Fee Schedule.
    • Reimburse at 70% of the first appearance on a Medicare Clinical Laboratory Fee Schedule or a carrier's fee schedule.

    Covered services without a published Medicare fee

    For dates of service January 1, 2022, and thereafter, covered diagnostic pathology services without a published Medicare Clinical Laboratory Fee Schedule fee are reimbursed as follows:

    Policy Summary
    PayerHighmark Delaware
    PolicyDiagnostic Pathology Services
    Policy CodePolicy RP-074
    Change TypeAdministrative retirement
    Effective DateAug 1, 2022
    Last ReviewSep 1, 2025
    Next Review DateN/A
    Key ActionApply 51% of billed charge when no Medicare Clinical Laboratory Fee Schedule fee is published.
    SourceLink
    On This Page
    Diagnostic Pathology Reimbursement CriteriaReimbursement MethodologyApply the Appropriate Reimbursement Rule

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ALL of the following

    • ALL of the following

      • Service is a covered diagnostic pathology service.
      • The service does not have a published fee on the Medicare Clinical Laboratory Fee Schedule.
    • Reimburse at 51% of the billed charge.

    Reimbursement Methodology

    Fee-schedule reimbursement
    Reimbursement basisFirst appearance on a Medicare Clinical Laboratory Fee Schedule or a carrier's fee schedule
    Reimbursement percentage70%
    Applicable servicesDiagnostic Pathology services without pricing on the Medicare Clinical Laboratory Fee Schedule
    Billed-charge reimbursement
    Reimbursement basisBilled charge
    Reimbursement percentage51%
    Applicable servicesCovered Diagnostic Pathology services without a published fee on the Medicare Clinical Laboratory Fee Schedule

    Apply the Appropriate Reimbursement Rule

    Billing Rule

    Apply billed-charge reimbursement when no Medicare fee is published

    For covered Diagnostic Pathology services that do not have a published fee on the Medicare Clinical Laboratory Fee Schedule, reimburse at 51% of the billed charge for dates of service January 1, 2022, and thereafter.

    Billing Rule

    Apply fee-schedule-based reimbursement

    For dates of service January 1, 2022, and thereafter, reimburse Diagnostic Pathology services at 70% of the first appearance on a Medicare Clinical Laboratory Fee Schedule or a carrier’s fee schedule.